Therapeutic peptides derived from urokinase plasminogen...

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 14/435 (2006.01)

Patent

CA 2595935

The present invention relates to a chemotactically active epitope derivable from the urokinase receptor, a mutated peptide that acts as an inhibitor of chemotaxis, and their therapeutic use.

L'invention concerne un épitope chimiotactiquement actif, qui peut être dérivé du récepteur de l'urokinase, un peptide muté qui agit comme inhibiteur de la chimiotaxie, et l'utilisation thérapeutique de ceux-ci.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Therapeutic peptides derived from urokinase plasminogen... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic peptides derived from urokinase plasminogen..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic peptides derived from urokinase plasminogen... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1456083

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.